ProPhase Labs Analyst Ratings
ProPhase Labs Analyst Ratings
Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
---|---|---|---|---|---|
02/23/2023 | 101.34% | HC Wainwright & Co. | → $15 | Reiterates | → Buy |
02/16/2023 | 101.34% | HC Wainwright & Co. | → $15 | Reiterates | → Buy |
02/07/2023 | 101.34% | HC Wainwright & Co. | → $15 | Reiterates | → Buy |
11/11/2022 | 101.34% | HC Wainwright & Co. | $14 → $15 | Maintains | Buy |
05/17/2022 | 87.92% | HC Wainwright & Co. | $16 → $14 | Maintains | Buy |
03/31/2022 | 114.77% | HC Wainwright & Co. | $15 → $16 | Maintains | Buy |
01/14/2022 | 101.34% | HC Wainwright & Co. | $12 → $15 | Maintains | Buy |
12/20/2021 | 61.07% | HC Wainwright & Co. | → $12 | Initiates Coverage On | → Buy |
10/13/2021 | — | Dawson James | Downgrades | Buy → Neutral |
日期 | 上行/下行 | 分析公司 | 目标价格变化 | 评级变化 | 上一次/当前评级 |
---|---|---|---|---|---|
02/23/2023 | 101.34% | HC Wainwright公司 | →$15 | 重申 | →购买 |
02/16/2023 | 101.34% | HC Wainwright公司 | →$15 | 重申 | →购买 |
02/07/2023 | 101.34% | HC Wainwright公司 | →$15 | 重申 | →购买 |
2022年11月11日 | 101.34% | HC Wainwright公司 | $14→$15 | 维护 | 买 |
2022/05/17 | 87.92% | HC Wainwright公司 | $16→$14 | 维护 | 买 |
03/31/2022 | 114.77% | HC Wainwright公司 | $15→$16 | 维护 | 买 |
2022年01月14日 | 101.34% | HC Wainwright公司 | $12→$15 | 维护 | 买 |
12/20/2021 | 61.07% | HC Wainwright公司 | →$12 | 开始承保 | →购买 |
10/13/2021 | - | 道森·詹姆斯 | 评级下调 | 购买→中性 |
What is the target price for ProPhase Labs (PRPH)?
前期实验室(PRPH)的目标价格是多少?
The latest price target for ProPhase Labs (NASDAQ: PRPH) was reported by HC Wainwright & Co. on February 23, 2023. The analyst firm set a price target for $15.00 expecting PRPH to rise to within 12 months (a possible 101.34% upside). 6 analyst firms have reported ratings in the last year.
HC Wainwright&Co.于2023年2月23日报告了前期实验室(纳斯达克:PRPH)的最新目标价。这家分析公司将目标价定为15美元,预计PRPH将在12个月内上涨至(可能上涨101.34%)。6家分析公司在过去一年公布了评级。
What is the most recent analyst rating for ProPhase Labs (PRPH)?
前期实验室(PRPH)的最新分析师评级是多少?
The latest analyst rating for ProPhase Labs (NASDAQ: PRPH) was provided by HC Wainwright & Co., and ProPhase Labs reiterated their buy rating.
前期实验室(纳斯达克代码:PRPH)的最新分析师评级由HC Wainwright&Co.提供,前期实验室重申其买入评级。
When is the next analyst rating going to be posted or updated for ProPhase Labs (PRPH)?
下一次发布或更新前期实验室(PRPH)的分析师评级是什么时候?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of ProPhase Labs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for ProPhase Labs was filed on February 23, 2023 so you should expect the next rating to be made available sometime around February 23, 2024.
分析师在进行了广泛的研究后得出了股票评级,其中包括查阅公共财务报表,与前期实验室的高管和客户交谈,以及听取收益电话会议。大多数分析师每三个月就会这样做一次,所以你每年应该会得到每家公司每家公司的4个评级。前期实验室的最后一次评级是在2023年2月23日提交的,所以你应该预计下一次评级将在2024年2月23日左右的某个时候公布。
Is the Analyst Rating ProPhase Labs (PRPH) correct?
分析师对前期实验室(PRPH)的评级正确吗?
While ratings are subjective and will change, the latest ProPhase Labs (PRPH) rating was a reiterated with a price target of $0.00 to $15.00. The current price ProPhase Labs (PRPH) is trading at is $7.45, which is within the analyst's predicted range.
虽然评级是主观的,并将发生变化,但最新的前期实验室(PRPH)评级被重申,目标价在0.00美元至15.00美元之间。前期实验室(PRPH)目前的交易价格为7.45美元,在分析师的预测范围内。